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Abstract
Rationale Impulsivity is a cardinal feature of attention
deficit hyperactivity disorder (ADHD), which is thought to
underlie many of the cognitive and behavioural symptoms
associated with the disorder. Impairments on some measures
of impulsivity have been shown to be responsive to
pharmacotherapy. However, impulsivity is a multi-factorial
construct and the degree to which different forms of
impulsivity contribute to impairments in ADHD or respond
to pharmacological treatments remains unclear.
Objectives The aims of the study were to assess the effects
of methylphenidate (MPH) on the performance of children
with ADHD on measures of reflection–impulsivity and
response inhibition and to compare with the performance of
healthy volunteers.
Methods Twenty-one boys (aged 7–13 years) diagnosed
with ADHD underwent a double-blind, placebo-controlled
trial of MPH (0.5 mg/kg) during which they performed the
Information Sampling Task (IST) and the Stop Signal Task.
A healthy age- and education-matched control group was
tested on the same measures without medication.
Results Children with ADHD were impaired on measures
of response inhibition, but did not demonstrate reflection–
impulsivity on the IST. However, despite sampling a similar
amount of information as their peers, the ADHD group
made more poor decisions. MPH improved performance on
measures of response inhibition and variability of response,
but did not affect measures of reflection–impulsivity or
quality of decision-making.
Conclusions MPH differentially affected two forms of
impulsivity in children with ADHD and failed to ameliorate
their poor decision-making on the information sampling test.
Keywords Impulsivity.Reflection–impulsivity.
Response inhibition.Methylphenidate.ADHD.
Stopsignal.Decision-making.Cognitiveenhancement.
Disinhibition.Cognition
Introduction
Attention deficit hyperactivity disorder (ADHD) is a
prevalent neuropsychiatric disorder for which impulsivity
(e.g. tendency to interrupt, difficulty awaiting turn) is
considered to be a cardinal feature (Barkley 1997; Halperin
et al. 1995; Nigg 2000). Children with ADHD are often
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displaying more ‘impulsive’ behaviours than their peers
(Chamberlain and Sahakian 2006). These clinical symptoms
can be quantified using laboratory tasks of impulsivity in
children. Given the multi-factorial nature of the impulsivity
construct (Evenden 1999;R e y n o l d s2006), existing tasks fall
within three core domains. Inhibition of pre-potent responses
can be assessed with the Stop Signal Task (SST; Logan et al.
1984) or with go/no go (Aron and Poldrack 2005)o r
continuous performance tasks (CPT; Rosvold and Delgado
1956). Delay impulsivity, defined as the choice of a
smaller immediate reward over larger delayed reward can
be assessed with tasks of temporal discounting or delay-
of-gratification (Scheres et al. 2006; Schweitzer and
Sulzer-Azaroff 1995;S o n u g a - B a r k ee ta l .1992). A third
domain,which has received less attention, refersto impulsivity
at the pre-decisional stage, when the individual gathers and
evaluates information. Kagan (1966) first defined the concept
of reflection–impulsivity using his Matching Familiar Figures
Test (MFFT) where the aim is to determine which of six
figures is identical to a standard. Kagan defined ‘reflectives’
as those subjects with long decision latencies but low error
rates, whilst ‘impulsives’ decided quickly and made more
errors. ‘Reflectives’ not only gather more information, but
also use a more systematic approach to comparing the figures
than ‘impulsives’(Drake 1970). Hyperactive children (i.e. the
diagnosis that later became ADHD in the DSM-III) were
classed as ‘impulsives’ more often than their peers on the
MFFT (Messer 1976; Sandoval 1977). However, Block et al.
(1974) criticised the concept of reflection–impulsivity as
defined by the MFFT for disregarding those subjects who
perform quickly and well or slowly and poorly simply
because they do not meet the original definition of ‘reflective’
or ‘impulsive’ (Block et al. 1974).
An alternative measure of reflection–impulsivity, the
Information Sampling Task (IST; (Clark et al. 2006)), has
recently been developed to circumvent some of the
criticisms of the MFFT and to allow for a more direct
analysis of information sampling and quality of decision-
making. In this task, subjects sample information from a
covered array of 25 boxes in order to decide which of two
colours lies in the majority under the board. Although the
subjects are able to sample information until a point of
complete certainty, healthy young adults typically make
their decision at a point of uncertainty, such that there is
around a 20% chance of error. Substance users dependent
upon stimulants or opiates, as well as regular cannabis
users, show impulsivity and lack of sufficient sampling
(Clark et al. 2006, 2008). One objective of the present study
was to examine task performance on the IST in children
with ADHD in a case–control design. A further aim was to
characterise the effects of ADHD treatment on this variety
of impulsivity.
Methylphenidate (MPH) is the first-line treatment for
ADHD and acts to increase dopamine and noradrenaline
availability by blocking their reuptake (Berridge et al.
2006). MPH remediates impulsivity in children and adults
with ADHD on behavioural symptom ratings (Solanto et al.
2001) as well as laboratory tests of response inhibition
(Aron et al. 2003; Konrad et al. 2004; Tannock et al. 1989)
and the MFFT (Brown and Sleator 1979).
In this study, we compared the effects of MPH on two
forms of impulsivity: response inhibition measured by the
SST (Aron et al. 2003) and reflection–impulsivity measured
by the IST (Clark et al. 2006).
Methods
Methods and materials
Parental written informed consent and ethics committee
approval were obtained. Patients were regular attendees at a
childhood ADHD outpatient clinic and were consecutively
referred to the study by their psychiatrists. All patient
participants had undergone a psychiatrist-led 3-h clinical
assessment based on Kiddie-Schedule for Affective Disorders
and Schizophrenia and provided developmental and family
histories and teacher reports as part of standard care at the
outpatient clinic. All met the DSM-IV guidelines for ADHD
combined type, including pervasiveness of symptoms (APA
1994) and were stabilised on MPH for therapeutic purposes
prior to their referral to the study. ADHD patients (N=21)
were males, aged 7–13 years with no primary learning
disabilities or concomitant neurological, psychiatric or
behavioural disorders (except history of oppositional defiant
disorder; N=14). A healthy control group (HC; N=21; aged
7–12 years) was recruited with posters from the local
community. Groups were matched for age and years of
education.
The ADHD boys underwent a double-blind, placebo-
controlled, cross-over design of placebo or a single 0.5-mg/
kg dose (rounded up to the nearest 0.5 mg) of immediate-
release MPH delivered in capsules. One child received
0.25 mg/kg (10 mg) since his regular MPH dose with
therapeutic efficacy was low in comparison with his higher
bodyweight. Participants abstained from MPH for 21–28 h
(approximately five to seven half-lives) prior to testing
sessions. MPH reaches peak plasma concentration in
approximately 2 h (Volkow et al. 2002). Questionnaires
were completed once at the start of a visit to avoid treatment
effects. Neuropsychological testing began at least 11/2 h after
capsules were ingested. HCs attended two sessions but
received no capsules. Sessions were separated by approxi-
mately 1–2 weeks. For case-controlled comparisons, each HC
participanthadhis firstorsecondvisit randomlydesignatedas
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visit and test order to the ADHD-placebo sessions.
Participants completed the Junior I6 questionnaire
(Eysenck 1981), which is designed to measure self-reported
impulsive, venturesome and empathetic traits, as well as the
Mood and Feeling Questionnaires (Wood et al. 1995), a
measure of depressive symptoms. Parents completed
disruptive behaviour questionnaires [Achenbach Child
Behaviour Checklist (Achenbach 1991); Conners Symptom
Behaviour Checklist (Conners 1989)] based on their sons’
behaviour without medication. The order of task adminis-
tration and task conditions were counter-balanced and
matched between groups.
Information Sampling Task
The IST (Clark et al. 2006) is a measure of ‘reflection–
impulsivity’. Subjects were told they would be presented
with ten trials in each of two conditions [fixed win (FW),
decreasing win (DW)] and that the task would last for
10 min. On each trial, a 5×5 matrix of grey boxes with two
larger coloured panels below it was presented. Subjects
were told to press on a box to reveal its colour and to open
as many boxes as they chose prior to deciding which of the
two colours they thought was in the majority amongst the
25 boxes. Boxes remain open for the duration of the trial to
minimise working memory load. To register their decision,
they pressed on one of the two coloured panels displayed.
In the FW condition, if the subject chose correctly, they
earned 100 points, but lost 100 points if they chose
incorrectly. In the DW condition, subjects begin with the
ability to win 250 points, but with every box they opened
the amount they could win decreased by 10 points. An
incorrect choice was still penalised with a loss of 100 points
regardless of the amount of boxes opened. Therefore, in the
FW condition, extensive information sampling prior to
decision was optimal, whilst in order to gain points in the
DW condition the subject must adjust to sample less
information. A variable inter-trial interval was used such
that the minimum trial duration was 30 s (e.g. if the subject
responded after 10 s, the inter-trial interval would be 20 s).
This feature was included to prevent unduly rapid responses
leading to shorter task duration and thus an earlier escape of
the experimental setting. This task is described in more
detail by Clark et al. (2006).
Within each condition (FW and DW), there are five key
measures. ‘Boxes opened’ is the number of boxes they chose
to open, which represents the amount of information they
sample prior to making a decision. ‘Box adjustment’ is the
differences in number of boxes opened in the FW versus DW
conditions and represents the degree to which subjects adjust
their behaviour to the reward contingencies. ‘Quality of
information’ is the probability that the colour in the visible
majority at the time of choice is the true majority colourgiven
the number of boxes remaining covered and assuming each
uncovered box has a 0.5 probability of being each colour. For
details of the calculation, see Clark et al. (2006). ‘Quality of
information’ is the primary measure for information sam-
pling on this task since it accounts for the amount of boxes
opened as well as the proportion of each colour visible in the
uncovered areas of the matrix at the time of decision.
‘Choice latency’ is the time between opening the final box
and guessing which colour is in the majority within the
matrix. A ‘poor decision’ is when the colour in the minority
amongst the unveiled boxes is chosen.
A further measure, ‘sampling errors’, was employed to
confirm that the model of ‘reflection–impulsivity’ provides a
reasonable account of the data. This measure was not used to
analyse subjects’ task performance. Sampling errors occur
when the colour in the visible majority is chosen, but by
chance is not the colour within the majority of the matrix. In
a reflection–impulsivity task, the long-term probability of
sampling errors should be inversely related to the quality of
information: such errors are more likely to occur when less
information is sampled (i.e. fewer boxes are opened).
Stop Signal Task
The SST (Aron et al. 2003) is a well-established measure of
response inhibition. On each trial, subjects are asked to
make a rightward or leftward button press as quickly as
possible when presented with an arrow in the centre of the
screen pointing in the corresponding direction (go stimu-
lus). On a minority of the trials (25%), an auditory ‘stop
signal’ beep is presented at a variable delay (stop signal
delay, SSD) following the go stimulus. Subjects are
instructed to inhibit their responses on the trials with a
stop signal beep. Subjects complete five blocks of 64 trials;
each of the SSD is titrated to the subject’s ability using a
tracking algorithm (Osman et al. 1990) to converge on 50%
successful stop rate. The primary outcome measure is stop
signal reaction time (SSRT), an estimate of the subject’s
capacity for inhibiting pre-potent motor responses. To
ensure accurate estimation of the SSRT for subjects who
did not converge exactly on 50% successful stops, the
SSRT was computed using the integration method (Logan
1994). The SSRT as estimated by the integration method
produced qualitatively similar results as the race-model
estimation in this data set. Additional measures of interest
are the median (median go) and standard deviation (SD;
variability go) of the go reaction times.
Statistical analyses
T tests or non-parametric equivalents (Wilcoxon signed
ranks or Mann–Whitney U tests), where appropriate, and
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MPH and healthy controls on IST and SST measures, rating
scales and demographic variables. Data were examined for
statistical outliers (defined as >3×interquartile range outside
either quartile boundary) before analysis. The exclusion of
outliers did not alter the pattern or significance of results. On
measures that significantly improved on MPH, ADHD-MPH
was compared directly with the HC group. Effect sizes were
calculated as d=(μ1−μ2)/√[(σ1
2+σ2
2)/2] (Dunlap et al.
1996). Exploratory correlations (Pearson’s or Spearman’s)
were carried out between the core task measures that
showed significant impairments or changes on MPH and
behavioural ratings. Due to the large number of correlations,
only those significant to p<0.01 will be reported.
Results
ADHD and HC groups were matched for age (t=−0.872,
p=0.388; meanADHD=10.00, SDADHD=2.04; meanHC=
10.47, SDHC=1.43), test order (t=−0.302, p=0.765), visit
used (t=0.302, p=0.765), days between visits (t=−0.710,
p=0.482), years of education (t=−1.063, p=0.297) and
distribution of younger (7–10) versus older (11–13)
children (df=1, χ
2=1.52, p=0.22). The ADHD group had
significantly higher disruptive behaviour ratings (Achen-
bachTotal t=6.795, p<0.001; ConnersTotal t=8.777, p<
0.001) and a trend towards higher depressive symptoms
(Mood and Feeling Questionnaire t=1.852; p=0.072). Two
ADHD subjects who received MPH on session 1 did not
return for their second sessions and were excluded from the
analyses.
Information Sampling Task
Participants demonstrated sensitivity to the task contin-
gencies by opening fewer boxes in the DW condition than
the FW condition (HC z=−3.980, p<0.001; ADHD-
placebo z=−3.680, p<0.001; ADHD-MPH z=−3.920, p<
0.001). A core criterion for a test of reflection–impulsivity is
that the extent of information sampling should predict the
accuracyofthe eventualdecision.Thiscriterionwasgenerally
evident in the data as negative correlations between sampling
errors and the number of boxes opened in the FW condition
(HC r=−0.771, p<0.001; ADHD-placebo r=−0.634, p=
0.005; ADHD-MPH r=0.109, p=0.648).
IST group effects (ADHD-placebo versus healthy controls)
ADHD-placebo did not differ significantly from healthy
controls in either condition on the amount of boxes opened
(FW z=−0.620, p=0.549, d=0.18; DW z=−0.930, p=
0.364, d=0.18), box adjustment (z=−0.592, p=0.568, d=
0.28), choice latency (FW z=−1.155, p=0.257, d=0.37;
DW z=−1.465, p=0.148, d=0.51) or quality of information
available at the time of choice (FW z=−0.509, p=0.626, d=
0.13; DW z=1.296, p=0.202, d=0.40; see Table 1). In both
conditions, ADHD-placebo made significantly more poor
decisions(i.e.chosethecolourinthevisibleminority)thanthe
HC group (FW z=−2.954, p=0.006,d=1.06;DWz=−3.097,
p=0.003, d=0.90; see Fig. 1a).
IST drug effects (ADHD-MPH versus ADHD-placebo)
MPHdidnot significantlyalter the performanceofthe ADHD
group on the key IST measures. ADHD-MPH did not
Table 1 IST key measures
IST measure Group/session Fixed win, mean (SEM) Decreasing win, mean (SEM)
Boxes opened HC 16.83 (1.00) 7.66 (0.65)
ADHD-placebo 17.81 (1.45) 6.92 (1.13)
ADHD-MPH 16.26 (1.53) 5.83 (1.03)
Quality of information HC 0.86 (0.02) 0.70 (0.01)
ADHD-placebo 0.87 (0.03) 0.67 (0.02)
ADHD-MPH 0.83 (0.12) 0.66 (0.09)
Choice latency
a HC 3.34 (0.80) 1.78 (0.15)
ADHD-placebo 4.72 (0.92) 2.23 (0.24)
ADHD-MPH 3.96 (0.91) 2.38 (0.38)
Poor decisions HC 0.38 (0.15) 0.62 (0.03)
ADHD-placebo 1.33 (0.26) 1.94 (0.37)
ADHD-MPH 1.00 (0.23) 1.72 (0.48)
HC healthy control group, ADHD-placebo attention deficit hyperactivity group on placebo, ADHD-MPH attention deficit hyperactivity group on
methylphenidate
aLatency measures are reported in seconds
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of boxes opened (FW z=−0.828, p=0.407, d=0.25; DW
z=−1.045, p=0.296, d=0.24), box adjustment (t=−0.251,
p=0.805, d=0.07), choice latency (FW z=−1.328, p=0.184,
d=0.20; DW z=−0.240, p=0.811, d=0.11), quality of
information available at the time of choice (FW z=−1.086,
p=0.278, d=0.35; DW z=−0.806, p=0.420, d=0.12) or
number of poor decisions (FW z=−1.078, p=0.281,d=0.32;
DW z=−0.405, p=0.685, d=0.12).
IST effects of trial type (poor decision trials versus sensible
decision trials)
To further investigate the higher rates of poor decisions in the
ADHDgrouponplacebo,posthocanalyseswerecarriedoutto
compare trials where poor decisions were made with sensible
decision trials within each group and condition (see Table 2).
Within ADHD-placebo, poor-quality decision trials
did not differ from sensible trials in terms of choice
latency (FW z=−0.245, p=0.807, d=0.10;DWz=−0.785,
p=0.433, d=0.10). However, the quality of information
available at the time of choice was lower for ADHD-
placebo on poor decision trials than sensible trials in the
FW condition only (FW z=−2.29, p=0.022, d=0.66; DW
z=−0.722, p=0.470, d=0.36). Within ADHD-MPH, poor
and sensible decision trials did not differ significantly in
terms of quality of information available at the time of
choice (FW z=0.000, p=1.000, d=0.30;DWz=−0.80, p=
0.424, d=0.35), but ADHD-MPH had significantly shorter
choice latencies on poor-quality decision trials than
sensible trials in the FW condition only (FW z=−2.045,
p=0.041, d=0.67; DW z=−1.511, p=0.131, d=0.51).
In addition, ADHD-MPH did not significantly differ
from ADHD-placebo on choice latency or quality of
information measures within poor or sensible decision trials
in either condition.
IST effects of task duration on probability of correct choice
A post hoc analysis was performed to determine whether
higher rates of errors in the ADHD group were related to
fatigue or loss of motivation across the duration of the task.
The probability that the subjects’ choices were correct
given the information available at the time of decision was
calculated for each trial using a variant of the equation for
‘quality of information’. Whilst ‘quality of information’
represents the probability of being correct if the subject
chooses the colour in the visible majority at the time of
decision (i.e. the ‘sensible’ choice), the calculation for
probability of correct choice instead considers the colour
actually chosen by the subject. Therefore, poor decisions
always have a probability of being correct of less than 0.5.
Fig. 1 Group and drug effects
on IST poor decisions and SST
SSRT
Table 2 IST poor decision trials versus sensible decision trials
IST measure Group/session Trial decision Fixed win, mean (SEM) Decreasing win, mean (SEM)
Quality of information ADHD-placebo Poor 0.79 (0.05) 0.64 (0.03)
Sensible 0.89 (0.02) 0.67 (0.02)
ADHD-MPH Poor 0.90 (0.05) 0.64 (0.04)
Sensible 0.85 (0.02) 0.68 (0.02)
Choice latency
a ADHD-placebo Poor 5.04 (1.67) 2.37 (0.35)
Sensible 4.53 (0.91) 2.25 (0.27)
ADHD-MPH Poor 2.32 (0.54) 2.00 (0.31)
Sensible 4.50 (0.90) 2.93 (0.53)
ADHD-placebo attention deficit hyperactivity group on placebo, ADHD-MPH attention deficit hyperactivity group on methylphenidate
aLatency measures are reported in seconds
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poor decisions but the data meets the assumptions of
normality necessary for inclusion in an analysis of variance
(ANOVA). A mixed-model ANOVA measured the change
in the probability of being correct across the within-subject
factors of trial (1–10) and condition (FW, DW) and
between-subject factors of group (ADHD-placebo, HC)
and condition order (FW–DW, DW–FW). There were
significant main effects of group (F=5.804, p=0.021) and
trials (F=7.668, p<0.001) on the probability of being
correct. The main effect of trials was due to a fluctuation
from trial to trial (the precise sequence of colours revealed
in a session was taken from the same pseudo-random
sequence for all participants), rather than a clear trend across
the task duration. There were no significant trial by group
(F=1.434, p=0.186), trial by condition order (F=1.231, p=
0.283) or trial by group by condition order (F=1.469, p=
0.168) interactions. Thus, this analysis provides no evidence
to suggest that group differences arose through differences in
fatigue or motivation over the course of a session.
Stop Signal Task
SST group effects (ADHD-placebo versus healthy controls)
Compared with the HC group on the SST, ADHD-placebo had
significantly slower median go reaction time (F=3.20, p=
0.005, d=1.00), larger SD of go reaction times (z=−4.049, p<
0.001, d=1.53) and longer SSRTs (t=3.78, p=0.001, d=1.28;
see Table 3).
SST drug effects (ADHD-MPH versus ADHD-placebo)
Compared with ADHD-placebo, ADHD-MPH had less
variable go reaction times (z=−3.501, p<0.001, d=1.10)
and shorter SSRTs (t=−4.169, p=0.001,d=1.54), but did not
significantly differ on median go reaction times (t=−1.573,
p=0.133, d=0.23).
SST medicated ADHD group effects (ADHD-MPH versus
healthy controls)
ADHD-MPH and HC groups were only directly compared
on measures that were significantly affected by MPH.
ADHD on medication (ADHD-MPH) no longer signifi-
cantly differed from healthy controls on SSRT (t=−4.75,
p=0.638, d=0.26; see Fig. 1b) or SD of go reaction time
(z=−1.648, p=0.099, d=0.50).
Associations between measures of impulsivity
Measures from the SST (SSRT, SD of go reaction time) and
IST (quality of information, poor decisions) were compared
with each other as well as with self-rated trait (I6
impulsivity, venturesomeness, empathy subscales) and
parent-rated behavioural (Conners total score, Achenbach
total score) questionnaires.
In the ADHD group, higher self-rated impulsivity (I6)
was associated with reduced quality of information
tolerated in the FW condition on placebo (r18=−0.661,
p=0.003; see Fig. 2). Higher self-rated trait venturesome-
ness (I6), which involves questions in regard to risky but
hedonic adventures, was associated with better response
inhibition (SSRT) in the ADHD group on MPH (ADHD-
Table 3 SST key measures
SST measure Group/session Mean (SEM)
SSRT HC 263.93 (20.0)
ADHD-placebo 376.84 (22.01)
ADHD-MPH 242.80 (19.30)
Median go RT
a HC 442.76 (22.76)
ADHD-placebo 548.42 (30.86)
ADHD-MPH 520.21 (26.42)
SD go RT
a HC 175.46 (73.61)
ADHD-placebo 530.18 (77.39)
ADHD-MPH 225.36 (28.10)
HC healthy control group, ADHD-placebo attention deficit hyperac-
tivity group on placebo, ADHD-MPH attention deficit hyperactivity
group on methylphenidate, SSRT stop signal reaction time
aReaction time (RT) measures are reported in milliseconds
Fig. 2 More uncertainty tolerated prior to decision-making associated
with self-rated impulsivity in ADHD-placebo
536 Psychopharmacology (2009) 202:531–539MPH; r19=−0.605, p=0.006). The reason for this associ-
ation requires further investigation.
In the ADHD group, self-rated empathy, but not
impulsivity or venturesomeness (I6), correlated negatively
with parent-rated disruptive behaviours (AchenbachTotal
r=−0.612, p=0.003) and ADHD symptoms (ConnersTotal
r=−0.599, p=0.005; see Fig. 3).
Discussion
On the SST, response inhibition was improved by MPH as
was variability of reaction time. These findings replicate
previous results in children (Konrad et al. 2004; Lijffijt et al.
2006; Tannock et al. 1989) and adults (Aron et al. 2003)
with ADHD. On the IST, ADHD children did not differ from
healthy control childrenin terms ofthe amountof information
they sampled, the degree of uncertainty tolerated prior to
making a decision or the speed at which they made their final
choice. However, the ADHD group on placebo made
significantly more poor decisions than the healthy controls.
MPH did not significant affect any of the primary IST
measures. Post hoc analyses revealed that within the ADHD
group on placebo, these subjects tolerated a lower probability
of being correct on the trials where they made poor decisions,
signifying a degree of cognitive impulsivity contributing to
their higher error rate. These problems were not ameliorated
by MPH. The ADHD group on MPH took less time to make
their final decision on the trials where they made poor
decisions compared with the trials where they chose the
colour in the visible majority, perhaps suggesting less
attention to the trials where errors were made.
The lack of correlations between IST and SST measures
is consistent with the idea that response inhibition and
reflection–impulsivity are separate forms of impulsivity
(Evenden 1999). Despite the widely accepted value of both
rating scales and laboratory measures, it is common to find
a lack of statistical associations between these measures of
impulsivity (Lijffijt et al. 2004; Swann et al. 2002). This
has been attributed to unreliable or biased reporting on
ratings scales (e.g. children’s poor insight into their
personality or behaviour; tendency for adults to respond
with socially appropriate answers) or to the different forms
of measurement tapping into different aspects of impulsiv-
ity (e.g. trait versus state). Therefore, it is significant that in
the children with ADHD off medication, toleration of less
quality of information prior to deciding was correlated
strongly with their self-rated impulsivity. Parent ratings of
disrupted behaviours did not relate to IST or SST measures,
they were also not related to children’s self-rated impulsiv-
ity. The strong association between children’s self-rated
empathy and parent-rated behavioural scales suggests that
poor social perception or difficulty appreciating the impact of
one’s behaviour on others (Clark et al. 1999) may contribute
to disruptive behaviours in ADHD.
This study is the first demonstration of the IST in healthy
children or children with ADHD, both on and off MPH.
The lack of group effects on some measures of IST was
interesting, given that impulsive responding (e.g. less
information sampling prior to deciding) was previously
demonstrated in current and former drug users (Clark et al.
2006, 2008) as well as adults with major depressive
disorder (Taylor Tavares et al. 2007) on this task. The
children appeared to comprehend the task requirements by
adjusting their information sampling according to the
condition (FW, DW) and choosing the colour in the visible
majority on the majority of trials. Poor quality of decision-
making distinguished children with ADHD from their
peers, but was not accompanied by significantly less
information sampling or differences in speed of decision-
making. Therefore, the impairment in quality of decision-
making on IST does not appear to be attributable to greater
motor impulsivity in this context. The fact that patients do
tolerate a lower quality of information on the trials in which
they make errors may suggest that fluctuations in their
attention or cognitive impulsivity across the duration of the
task may contribute to their poor-quality decisions. These
effects cannot easily be explained by reduced motivation as
a result of fatigue in the ADHD group since statistical
analyses showed no group differences on the performance
effects of time on task. In regards to the limitations of this
Fig. 3 Self-rated empathy not impulsivity associated with behaviour
ratings
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larger group of ADHD patients including other ADHD
subgroups and females.
The traditional concept of reflection–impulsivity predicts
that impulsive subjects would respond quickly (i.e. prior to
gathering sufficient information) and consequently make
more errors than reflective subjects (Kagan 1966). Howev-
er, we demonstrated increased errors without significantly
lower levels of information sampling in the ADHD group.
These findings are consistent with Block et al. (1974) who
found that symptoms associated with hyperactivity in
healthy children were most commonly observed in those
subjects who made many errors on the MFFT despite
responding slowly. In fact, subjects who responded quickly
and inaccurately were not more likely to display hyperac-
tive traits (Block et al. 1974). Although the prevalent
method of analysing the MFFT incorporates latency and
error rates, latency can be influenced by minor manipu-
lations, such as changing task instructions to encourage
slower responding. In contrast, error rates could only be
improved by teaching systematic strategies or presenting
the figures as component parts to encourage systematising
(Block et al. 1974). Therefore, they concluded that error
rates are a more reliable and stable measure of cognitive
style than latency.
The lack of impulsive information sampling in
children with ADHD with accompanying high error rates
suggests they may be failing to use the available
information to their advantage as well as their peers.
This tendency is not ameliorated by MPH, despite its
robust effects on other forms of impulsivity and response
control measured in the same session. Poor quality of
decision-making resistant to treatment with MPH has
been previously demonstrated in an earlier study of
children with ADHD on the Cambridge Gamble Task
(DeVito et al. 2008). Methods for improving decision-
making are, therefore, an important target for pharmaco-
logical as well as non-pharmacological treatments.
Conclusions
Although MPH reversed the impairments in motor
control and response inhibition in children with ADHD,
it did not significantly improve their poor quality of
decision-making.
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